India\'s Clinical Trials Ignore Major Killer Diseases, Focus
Top killers in India – diarrhea, TB, cardiovascular diseases and pulmonary diseases – rank abysmally low in the country’s clinical trial priorities that is heavily geared towards drug approvals in cancer, a new research study has revealed.
'Law in Numbers: Evidence Based Approach to Legal Reform,' authored by the Vidhi Centre for Legal Policy, says the top seven diseases in the country that accounted for almost half of all deaths in 2012 were associated with only 11.3% of all pharmaceutical clinical trials and 12.3% of all new marketing approvals. The disease that most clinical trials flocked to turned out to be Cancer, which doesn’t figure in the top ten causes of death in the country....